AGM/EGMJun 8, 2026, 04:12 PM
Achieve Life Sciences Proposes Doubling Authorized Shares to 300M
AI Summary
Achieve Life Sciences, Inc. announced its Annual Meeting of Stockholders on July 2, 2026, where shareholders will vote on several key proposals. The most significant proposal is to amend the certificate of incorporation to increase authorized common stock from 150 million to 300 million shares. This follows a recent April 2026 private placement that raised approximately $180 million gross proceeds. The company also announced changes to its board, reducing its size from thirteen to nine members, and the appointment of Andrew D. Goldberg as CEO and Lucian Iancovici as Chairman.
Key Highlights
- Annual Meeting of Stockholders scheduled for July 2, 2026.
- Proposal to increase authorized common stock from 150,000,000 to 300,000,000 shares.
- April 2026 private placement raised approximately $180.0 million gross proceeds.
- June 2025 public offering raised $45.0 million gross proceeds.
- Board of Directors to be reduced from thirteen to nine members.
- Andrew D. Goldberg appointed CEO and President in April 2026.
- Lucian Iancovici appointed Chairman of the Board effective June 8, 2026.
- $0.7 million paid to Adare Pharma Solutions for development agreements.
Price Impact
More from ACHV